Gainers
- Portage Biotech PRTG shares moved upwards by 20.6% to $1.7 during Wednesday's after-market session. The company's market cap stands at $33.6 million.
- BIMI Intl Medical BIMI stock rose 9.62% to $2.05. The market value of their outstanding shares is at $23.7 million.
- Molecular Partners MOLN shares increased by 9.6% to $5.48. The company's market cap stands at $180.0 million.
- Nemaura Medical NMRD shares rose 9.28% to $0.14. The market value of their outstanding shares is at $4.0 million.
- Bright Green BGXX stock rose 8.62% to $0.3. The company's market cap stands at $55.5 million.
- Celularity CELU shares rose 6.04% to $0.3. The market value of their outstanding shares is at $56.9 million.
Losers
- Biora Therapeutics BIOR shares declined by 11.5% to $1.16 during Wednesday's after-market session. The company's market cap stands at $31.5 million.
- ABVC BioPharma ABVC shares declined by 8.3% to $1.77. The company's market cap stands at $13.7 million.
- ENDRA Life Sciences NDRA shares declined by 7.86% to $1.29. The market value of their outstanding shares is at $10.9 million.
- Akanda AKAN shares fell 6.44% to $0.47. The market value of their outstanding shares is at $1.8 million.
- Ocean Biomedical OCEA shares fell 6.11% to $0.64. The market value of their outstanding shares is at $21.8 million.
- Shuttle Pharmaceuticals SHPH shares decreased by 5.67% to $0.5. The market value of their outstanding shares is at $7.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AKANAkanda Corp
$1.527.80%
BGXXBright Green Corp
$0.0640-56.8%
BIMIBIMI Holdings Inc
$0.00750-%
BIORBiora Therapeutics Inc
$0.4650-22.5%
CELUCelularity Inc
$2.350.86%
MOLNMolecular Partners AG
$5.447.09%
NDRAENDRA Life Sciences Inc
$5.41-1.80%
NMRDNemaura Medical Inc
$0.04764764900.0%
OCEAOcean Biomedical Inc
$0.6234-6.13%
PRTGPortage Biotech Inc
$5.63-5.54%
SHPHShuttle Pharmaceuticals Holdings Inc
$0.65021.58%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in